Every 424B that SurgePays, Inc. (SURG) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow SURG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SURG filings page.
SurgePays, Inc. is conducting a primary offering of 2,000,000 shares of common stock at a public offering price of $1.25 per share, for gross proceeds of $2,500,000 and estimated net proceeds of about $2.125 million. Underwriters have a 45‑day option to buy up to 300,000 additional shares to cover over‑allotments. After this sale, common stock outstanding is expected to be 23,433,037 shares, or 23,733,037 shares if the option is fully exercised.
The company plans to use the net proceeds mainly to expand its Lifeline wireless business and for working capital and general corporate purposes, with potential selective acquisitions. New investors will face immediate dilution of $1.66 per share relative to the offering price, and additional dilution could occur from existing options, warrants, convertible notes and equity plan reserves.
Separately, SurgePays issued $500,000 of secured convertible notes in January 2026 bearing 14.5% annual interest and maturing in 24 months, along with 21,625 commitment shares. The company also updates its at‑the‑market program, noting it may now sell only a very limited additional aggregate amount of common stock under General Instruction I.B.6.
SurgePays, Inc. is offering 2,000,000 shares of common stock at $1.25 per share in a primary underwritten offering. This implies gross proceeds of $2.5 million and approximately $2.125 million in estimated net proceeds, or about $2.47 million if the underwriters fully exercise their 300,000‑share over‑allotment option. The company plans to use the cash mainly to expand its Lifeline subsidized wireless business, and for working capital and general corporate purposes.
SurgePays had 21,433,037 shares outstanding as of January 20, 2026, and expects 23,433,037 shares outstanding after the base offering. New investors buying at $1.25 per share face immediate dilution of $1.52 per share based on the as‑adjusted net tangible book value. In addition, SurgePays recently issued $500,000 of secured convertible notes bearing 14.5% annual interest, convertible into common stock at prices between $4 and $12 per share, and granted underwriter warrants equal to 3% of the shares sold.
SurgePays, Inc. plans a new primary offering of common stock and pre-funded warrants under its existing shelf registration, with an underwriter over-allotment option and additional representative’s warrants tied to the deal size. The company also recently issued $500,000 of secured convertible notes bearing 14.5% annual interest, maturing in 24 months, which are convertible into common stock at prices between $4 and $12, and granted 21,625 commitment shares to the note investors. The notes rank senior to other obligations, can accelerate with default, and carry a higher default interest rate of 18% per year.
Net proceeds from the equity offering are intended mainly to expand SurgePays’ Lifeline wireless business and for working capital and general corporate purposes, with possible selective acquisitions. The company also updates its at-the-market program with Titan, stating it may sell up to an additional $1 of common stock under current Form S-3 public float limits, excluding $1,775,390.79 of shares already sold. As context, common shares outstanding were 21,433,037 as of January 20, 2026.